ADVERTISEMENT

Delhi has run out of Covaxin stock for 18-44 age group, says AAP MLA

125 jab centres at the risk of stopping operation

The Aam Aadmi Party (AAP) leader urged the Centre to replenish Covaxin and Covishield stocks and said otherwise "we will have no option but to stop vaccination drive". Shutterstock

Our Bureau, Agencies
New Delhi | Published 11.05.21, 07:53 PM

Delhi has run out of Covaxin stock for people in the 18-44 age group and will have to shut 125 centres where the coronavirus vaccine was being administered, AAP MLA Atishi said on Tuesday.

In an online briefing, she also said Delhi will get 2.67 lakh more doses of Covishield vaccine from the Centre by Tuesday evening.

ADVERTISEMENT

"We have run out of Covaxin stock for 18-44 age group and will have to shut 125 centres where it is being administered after Tuesday evening," Atishi said.

The Aam Aadmi Party (AAP) leader urged the Centre to replenish Covaxin and Covishield stocks and said otherwise "we will have no option but to stop vaccination drive".

She said that more than 1.39 lakh people were given vaccine jabs in the national capital on May 10, the highest daily figure since the inoculation started.

Notably, the Centre on Tuesday announced that the states and UTs which will receive over 7 lakh additional doses in the next three days, the Union Health Ministry said on Tuesday.

"More than 90 lakh COVID Vaccine doses (90,31,691) are still available with the states and UTs to be administered. States with negative balance are showing more consumption (including wastage) than vaccine supplied as they have not reconciled the vaccine they have supplied to Armed Forces," the ministry said.

States and UTs will receive 7,29,610 additional vaccine doses in addition within the next three days.

The ministry said the Government of India has been supporting the nationwide vaccination drive by providing COVID vaccines free of cost to states and UTs.

Coronavirus Pandemic Covaxin
Follow us on:
ADVERTISEMENT